Glycine Antagonist (GV150526) in Acute Stroke: A Multicentre, Double-Blind Placebo-Controlled Phase II Trial

Publisher： Karger

E-ISSN： 1421-9786|11|1|20-29

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.11, Iss.1, 2001-01, pp. : 20-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

By  

Cerebrovascular Diseases, Vol. 20, Iss. 5, 2005-11 ,pp. : 304-309

Karger

Access to resources Recommend Favorite

Effect of the Glycine Antagonist Gavestinel on Cerebral Infarcts in Acute Stroke Patients, a Randomized Placebo-Controlled Trial: The GAIN MRI Substudy

By  

Cerebrovascular Diseases, Vol. 21, Iss. 1-2, 2006-01 ,pp. : 106-111

Karger

Access to resources Recommend Favorite

A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 3, Iss. 1, 2013-12 ,pp. : 459-467

Karger

Access to resources Recommend Favorite

Effect of Methylphenidate and/or Levodopa Combined with Physiotherapy on Mood and Cognition after Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

European Neurology, Vol. 66, Iss. 1, 2011-06 ,pp. : 7-13

Karger

Access to resources Recommend Favorite

Long-Term Antidepressant Treatment with Moclobemide for Aphasia in Acute Stroke Patients: A Randomised, Double-Blind, Placebo-Controlled Study

By  

Cerebrovascular Diseases, Vol. 19, Iss. 2, 2005-02 ,pp. : 125-132

Karger

Access to resources Recommend Favorite